Oxford Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Oxford Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,476	Closed	-$1.34M	–	1660
2019 Q4	$1.34M	Sell	23,476 -3,823	-14%	-$203K	0.04%	671
2019 Q3	$1.46M	Sell	27,299 -3,662	-12%	-$213K	0.04%	726
2019 Q2	$1.85M	Buy	30,961 +17,016	+122%	+$1.07M	0.04%	676
2019 Q1	$869K	Sell	13,945 -19,762	-59%	-$1.31M	0.02%	998
2018 Q4	$2.04M	Sell	33,707 -1,120	-3%	-$66.9K	0.05%	456
2018 Q3	$2.04M	Sell	34,827 -4,442	-11%	-$227K	0.04%	654
2018 Q2	$1.74M	Sell	39,269 -3,193	-8%	-$137K	0.03%	749
2018 Q1	$1.88M	Buy	42,462 +4,429	+12%	+$186K	0.04%	609
2017 Q4	$1.65M	Sell	38,033 -5,941	-14%	-$267K	0.04%	686
2017 Q3	$2.06M	Sell	43,974 -11,364	-21%	-$544K	0.04%	612
2017 Q2	$2.74M	Buy	55,338 +13,054	+31%	+$684K	0.05%	448
2017 Q1	$2.32M	Sell	42,284 -3,831	-8%	-$203K	0.06%	406
2016 Q4	$2.57M	Sell	46,115 -10,558	-19%	-$507K	0.09%	249
2016 Q3	$2.59M	Sell	56,673 -16,688	-23%	-$670K	0.08%	350
2016 Q2	$2.93M	Sell	73,361 -12,045	-14%	-$441K	0.1%	281
2016 Q1	$2.97M	Buy	85,406 +25,925	+44%	+$951K	0.09%	288
2015 Q4	$2.56M	Buy	+59,481	New	+$2.98M	0.06%	345

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Oxford Asset Management's BSTC Position: Q1 2020 in Review

Oxford Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2020, closing a stake of 23,476 shares — an estimated $1.34M sold.

Oxford Asset Management first reported a position in BSTC in Q4 2015 and held it in 17 quarters. The position peaked at $2.97M in Q1 2016. 113 funds tracked by Wall St. Rank hold BSTC as of Q1 2020.

Oxford Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 23,476 BioSpecifics Technologies Corp. shares in Q1 2020, an estimated $1.34M.
Oxford Asset Management first reported a position in BioSpecifics Technologies Corp. in Q4 2015 and held it in 17 quarters.
Oxford Asset Management's BioSpecifics Technologies Corp. position peaked at $2.97M in Q1 2016.
113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.